Search Results - "Zhu, Gongmin"
-
1
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
Published in Molecular cancer (06-11-2021)“…Colorectal cancer (CRC) is a heterogeneous disease at the cellular and molecular levels. Kirsten rat sarcoma (KRAS) is a commonly mutated oncogene in CRC, with…”
Get full text
Journal Article -
2
An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
Published in Cancer cell international (12-03-2021)“…Tumor metastasis is one of the leading reasons of the dismal prognosis of hepatocellular carcinoma (HCC). Epithelial-mesenchymal transition (EMT) is closely…”
Get full text
Journal Article -
3
Casp8 acts through A20 to inhibit PD‐L1 expression: The mechanism and its implication in immunotherapy
Published in Cancer science (01-07-2021)“…Immunotherapy targeting the PD‐L1/PD‐1 pathway is a novel type of clinical cancer treatment, but only small subsets of patients can benefit from it because of…”
Get full text
Journal Article -
4
Negative feedback loop of autophagy and endoplasmic reticulum stress in rapamycin protection against renal ischemia‐reperfusion injury during initial reperfusion phase
Published in The FASEB journal (01-11-2018)“…ABSTRACT Rapamycin, an immunosuppressant, is widely used in patients with kidney transplant. However, the therapeutic effects of rapamycin remain…”
Get full text
Journal Article -
5
Increased expression of caspase 1 during active phase of connective tissue disease
Published in PeerJ (San Francisco, CA) (22-07-2019)“…Key factors of pyroptosis play an important role in the inflammatory response to connective tissue disease (CTD). However, information on active and stable…”
Get full text
Journal Article -
6
EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients
Published in Aging (Albany, NY.) (03-02-2020)“…Bladder cancer is a leading cause of morbidity and mortality worldwide. Currently, immunotherapy has become a worthwhile therapy for bladder cancer. Tumor…”
Get full text
Journal Article -
7
Exosomes from human‐bone‐marrow‐derived mesenchymal stem cells protect against renal ischemia/reperfusion injury via transferring miR‐199a‐3p
Published in Journal of cellular physiology (01-12-2019)“…Renal ischemia/reperfusion (I/R) injury is the main reason for acute kidney injury (AKI) and is closely related to high morbidity and mortality. In this study,…”
Get full text
Journal Article -
8
BMSCs protect against renal ischemia‐reperfusion injury by secreting exosomes loaded with miR‐199a‐5p that target BIP to inhibit endoplasmic reticulum stress at the very early reperfusion stages
Published in The FASEB journal (01-04-2019)“…ABSTRACTBone marrow–derived mesenchymal stem cells (BMSCs) have been recently reported to play a variety of vital roles in organ and tissue damage repair,…”
Get full text
Journal Article -
9
A robust immune-related lncRNA signature for the prognosis of human colorectal cancer
Published in Bioscience reports (01-07-2022)“…Background Colorectal cancer (CRC) is one of the most prevalent malignant cancers worldwide. Immune related long non-coding RNAs (IRlncRNAs) are proved to be…”
Get full text
Journal Article -
10
Risk factors, follow-up, and treatment of urethral recurrence following radical cystectomy and urinary diversion for bladder cancer: a meta-analysis of 9498 patients
Published in Oncotarget (05-01-2018)“…Patients frequently undergo radical cystectomy and urinary diversion for treatment of bladder cancer. However, they remain at risk of urethral recurrence (UR)…”
Get full text
Journal Article -
11
Increased interleukin-11 associated with disease activity and development of interstitial lung disease in patients with rheumatoid arthritis
Published in Clinical and experimental rheumatology (01-01-2022)“…To investigate the association of serum interleukin-11 (IL-11) with disease activity and occurrence of interstitial lung disease (ILD) in patients with…”
Get more information
Journal Article -
12
Profiles of tumor‑infiltrating immune cells in renal cell carcinoma and their clinical implications
Published in Oncology letters (01-11-2019)“…Tumor-infiltrating immune cells (TIICs) are crucial for the clinical outcome of renal cell carcinoma (RCC), as they regulate cancer progression. TIICs have…”
Get full text
Journal Article -
13
C1QTNF6 Overexpression Acts as a Predictor of Poor Prognosis in Bladder Cancer Patients
Published in BioMed research international (2020)“…Background. Bladder cancer is one of the most common urinary malignancies. This study is aimed at providing some promising molecular biomarkers for bladder…”
Get full text
Journal Article